New genetically engineered DFS70 knock-out HEp-2 cells enable rapid and specific recognition of anti-DFS70 antibodies

References

• Chan EK, Damoiseaux J, Carballo OG, et al. Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014–2015. Front Immunol. 2015;6:412.
   PubMed Web of Science ®Google Scholar
• Basu A, Woods-Burnham L, Ortiz G, et al. Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2. Clin Immunol. 2015;161:241–250.
   PubMed Web of Science ®Google Scholar
• Watanabe A, Kodera M, Sugiura K, et al. Anti-DFS70 antibodies in 597 healthy hospital workers. Arthritis Rheum. 2004;50:892–900.
   PubMed Web of Science ®Google Scholar
• Mahler M, Parker T, Peebles CL, et al. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases. J Rheumatol. 2012;39:2104–2110.
   PubMed Web of Science ®Google Scholar
• Choi MY, Clarke AE, St Pierre Y, et al. The prevalence and determinants of anti-DFS70 autoantibodies in an international inception cohort of systemic lupus erythematosus patients. Lupus. 2017;26:1051–1059.
   PubMed Web of Science ®Google Scholar
• Vazquéz-Del Mercado MV, Gomez-Bañuelos E, Navarro-Hernandez RE, et al. Detection of autoantibodies to DSF70/LEDGFp75 in Mexican Hispanics using multiple complementary assay platforms. Autoimmun Highlights. 2017;8:1.
   PubMed Web of Science ®Google Scholar
• Fabris M, S Zago R, Tosolini P, et al. Anti-DFS70 antibodies: a useful biomarker in a pediatric case with suspected autoimmune disease. Pediatrics. 2014;134:e1706–e1708.
   PubMed Web of Science ®Google Scholar
• Fitch-Rogalsky C, Steber W, Mahler M, et al. Clinical and serological features of patients referred through a rheumatology triage system because of positive antinuclear antibodies. PLoS One. 2014;9:e93812.
   PubMed Web of Science ®Google Scholar
• Conrad K, Röber N, Rudolph S, Mahler M. DFS70 antibodies – biomarkers for the exclusion of ANA-associated autoimmune rheumatic diseases. Laboratoriums Med. 2015;38. DOI: 10.1515/labmed-2015-0040.
   Google Scholar
• Seelig CA, Bauer O, Seelig HP. Autoantibodies against DFS70/LEDGF exclusion markers for systemic autoimmune rheumatic diseases (SARD). Clin Lab. 2016;62:499–517.
   PubMed Web of Science ®Google Scholar
• Infantino M, Meacci F, Grossi V, et al. The clinical impact of anti-DFS70 antibodies in undifferentiated connective tissue disease: case reports and a review of the literature. Immunol Res. 2017;65:293–295.
   PubMed Web of Science ®Google Scholar
• Bizzaro N, Tonutti E, Villalta D. Recognizing the dense fine speckled/lens epithelium-derived growth factor/p75 pattern on HEp-2 cells: not an easy task! Arthritis Rheum. 2011;63:4036–4037.
   PubMedGoogle Scholar
• Bentow C, Fritzler MJ, Mummert E, et al. Recognition of the dense fine speckled (DFS) pattern remains challenging: results from an international internet based survey. Autoimmun Highlights. 2016;7:8.
   PubMed Web of Science ®Google Scholar
• Mahler M, Meroni PL, Andrade LE, et al. Towards a better understanding of the clinical association of anti-DFS70 autoantibodies. Autoimmun Rev. 2016;15:198–201.
   PubMed Web of Science ®Google Scholar
• Kuwabara N, Itoh Y, Igarshi T, et al. Autoantibodies to the lens epithelium-derived growth factor/transcription co-activator p75 (LEDGF/p75) in children with chronic nonspecific complaints and with positive antinuclear antibodies. Autoimmunity. 2009;42:492–496.
   PubMed Web of Science ®Google Scholar
• Ogawa Y, Sugiura K, Watanabe A, et al. Autoantigenity of DFS70 is restricted to the conformational epitope of C-terminal alpha-elical domain. J Autoimmun. 2004;23:221–231.
   PubMed Web of Science ®Google Scholar
• Bizzaro N, Tonutti E, Tampoia M, et al. Specific chemoluminescence and immunoasdorption tests for anti-DFS70 antibodies avoid false positive results by indirect immunofluorescence. Clin Chim Acta. 2015;451:271–277.
   PubMed Web of Science ®Google Scholar
• Muro Y, Sugiura K, Morita Y, et al. High concomitance of disease marker autoantibodies in anti-DFS70/LEDGF autoantibody-positive patients with autoimmune rheumatic disease. Lupus. 2008;17:171–176.
   PubMed Web of Science ®Google Scholar
• Bizzaro N, Pesente F, Cucchiaro F, et al. Anti-DFS70 antibodies detected by immunoblot methods: a reliable tool to confirm the dense fine speckles ANA pattern. J Immunol Methods. 2016;436:50–53.
   PubMed Web of Science ®Google Scholar
• Mariz HA, Sato EI, Barbosa SH, et al. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases. Arthritis Rheum. 2011;63:191–200.
   PubMed Web of Science ®Google Scholar
• Bentow C, Rosenblum R, Correia P, et al. Development and multi-center evaluation of a novel immunoadsorption method for anti-DFS70 antibodies. Lupus. 2016;25:897–904.
   PubMed Web of Science ®Google Scholar
• Mahler M, Fritzler MJ. The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 Cells for the diagnosis of systemic autoimmune diseases. Clin Dev Immunol. 2012;2012:494356.
   PubMedGoogle Scholar
• Malyavantham K, Suresh L. Analysis of DFS70 pattern and impact on ANA screening using a novel HEp-2 ELITE/DFS70 knockout substrate. Autoimmun Highlights. 2017;8:3.
   PubMed Web of Science ®Google Scholar
• Bizzaro N, Tonutti E, Visentini D, et al. Antibodies to the lens and cornea in anti-DFS70-positive subjects. Ann N Y Acad Sci. 2007;1107:174–183.
   PubMed Web of Science ®Google Scholar
• Miyara M, Albesa R, Charuel JL, et al. Clinical phenotypes of patients with anti-DFS70/LEDGF antibodies in a routine ANA referral cohort. Clin Dev Immunol. 2013;2013:703759.
   PubMed Web of Science ®Google Scholar
• Singh DP, Ohguro N, Chylack LT Jr, et al. Lens epithelium-derived growth factor: increased resistance to thermal and oxidative stresses. Invest Ophtalmol Visual Sci. 1999;40:1444–1451.
   PubMed Web of Science ®Google Scholar
• Ganapathy V, Casiano CA. Autoimmunity to the nuclear autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying to tell us? Arthritis Rheum. 2004;50:684–688.
   PubMed Web of Science ®Google Scholar
• Basu A, Cajigas-Du Ross CK, Rios-Colon L, et al. LEDGF/p75 overexpression attenuates oxidative stress-induced necrosis and upregulates the oxidoreductase ERP57/PDIA3/GRP58 in prostate cancer. PLoS One. 2016;11:e0146549.
   PubMed Web of Science ®Google Scholar
• Ochs RL, Mahler M, Basu A, et al. The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding. Clin Exp Med. 2016;16:273–293.
   PubMed Web of Science ®Google Scholar
• Gundín S, Irure-Ventura J, Asensio E, et al. Measurement of anti-DFS70 antibodies in patients with ANA-associated autoimmune rheumatic diseases suspicion is cost-effective. Autoimmun Highlights. 2016;7:10.
   PubMed Web of Science ®Google Scholar
• Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus (letter). Arthritis Rheum. 1997;40:1725.
   PubMed Web of Science ®Google Scholar
• Petri M, Orbai AM, Alarcon GS, et al. Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64:2677–2686.
   PubMed Web of Science ®Google Scholar
• Tonutti E, Bizzaro N, Morozzi G, et al. The ANA-reflex test as a model for improving clinical appropriateness in autoimmune diagnostics. Autoimmun Highlights. 2016;7:9.
   PubMed Web of Science ®Google Scholar